Tandem Diabetes Care Inc. (TNDM)
19.17
-0.11 (-0.57%)
At close: Mar 31, 2025, 3:59 PM
Tandem Diabetes Care Balance Sheet Statement
Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
Cash & Equivalents | 69.23M | 58.87M | 172.52M | 71.18M | 94.61M | 51.17M | 41.83M | 13.7M | 44.68M | 43.09M | 31.18M | 124.39M | 17.16M | 8.66M |
Short-Term Investments | 369.1M | 409.04M | 444.38M | 552.63M | 390.32M | 125.28M | 87.2M | 479K | 8.86M | 28.02M | 36.11M | 5.1M | n/a | n/a |
Long-Term Investments | 74.55M | n/a | 8.3M | n/a | n/a | n/a | n/a | 10M | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 4.24M | 37.56M | 19M | 9.09M | 580K | 708K | 128K | 10.1M | 107K | 499K | 691K | 642.75K | n/a | 25K |
Receivables | 114.58M | 105.56M | 114.72M | 110.72M | 82.19M | 46.59M | 35.19M | 20.79M | 11.17M | 14.05M | 7.65M | 5.3M | 2.44M | 224.89K |
Inventory | 149.61M | 157.94M | 111.12M | 68.55M | 63.72M | 49.07M | 19.9M | 26.99M | 21.2M | 17.54M | 11.91M | 10.33M | 6.26M | 50K |
Other Current Assets | 21.96M | 16.59M | 7.24M | 16.87M | 12.77M | 8.05M | 7.54M | 4.38M | 6.19M | 4.28M | 3.9M | 3.88M | 1.95M | 899.76K |
Total Current Assets | 724.49M | 747.99M | 849.98M | 811.52M | 637.24M | 276.14M | 187.88M | 64.16M | 92.09M | 106.98M | 90.75M | 148.99M | 27.81M | 9.78M |
Property-Plant & Equipment | 163.46M | 164.33M | 179.18M | 77.89M | 69.8M | 48.48M | 17.15M | 19.63M | 18.41M | 15.53M | 12.58M | 9.89M | 8.99M | 4.17M |
Goodwill & Intangibles | 925K | 2.78M | 4.63M | 6.64M | 8.8M | 777K | 1.13M | 1.46M | 1.78M | 2.11M | 2.44M | 2.7M | 3.02M | n/a |
Total Long-Term Assets | 243.17M | 204.67M | 202.81M | 93.62M | 79.18M | 49.97M | 18.41M | 31.19M | 20.3M | 18.14M | 15.71M | 13.23M | 12M | 4.2M |
Total Assets | 967.66M | 952.66M | 1.05B | 905.14M | 716.41M | 326.11M | 206.29M | 95.35M | 112.39M | 125.12M | 106.46M | 162.22M | 39.82M | 13.98M |
Account Payables | 44.73M | 49.59M | 55.73M | 28.03M | 17.8M | 17.75M | 6.82M | 5.15M | 7.51M | 5.23M | 1.95M | 2.35M | 1.69M | n/a |
Deferred Revenue | 11.83M | 43.99M | 18.84M | 10.18M | 6.08M | 3.87M | 4.6M | 2.53M | 5.21M | 1.82M | 840K | 411.42K | 1.88M | n/a |
Short-Term Debt | 18.21M | 17.06M | 26.24M | 18.56M | 18.84M | 12.64M | n/a | n/a | n/a | n/a | n/a | n/a | 4.2M | 12.86M |
Other Current Liabilities | 172.28M | 84.62M | 64.48M | 75.08M | 61.12M | 65.14M | 54.86M | 28.41M | 18.75M | 19.46M | 15.3M | 11.47M | 9.27M | 3.8M |
Total Current Liabilities | 247.05M | 195.26M | 165.29M | 131.86M | 103.85M | 99.4M | 66.29M | 36.09M | 31.48M | 26.52M | 18.09M | 14.6M | 17.05M | 16.66M |
Long-Term Debt | 455.36M | 398.61M | 406.76M | 305.39M | 218.9M | 14.06M | n/a | 76.54M | 78.96M | 29.27M | 29.44M | 29.4M | n/a | n/a |
Other Long-Term Liabilities | 2.15M | 31.83M | 23.92M | 17.84M | 27.36M | 17.67M | 8.73M | 11.87M | 7.88M | 5.46M | 4.36M | 2.68M | 128.82M | 68.61M |
Total Long-Term Liabilities | 457.51M | 443.77M | 447.55M | 340.17M | 246.26M | 31.73M | 8.73M | 88.41M | 86.84M | 35.13M | 33.8M | 32.08M | 128.82M | 68.61M |
Total Liabilities | 704.56M | 639.03M | 612.84M | 472.02M | 350.11M | 131.13M | 75.02M | 124.49M | 118.32M | 61.65M | 51.89M | 46.68M | 145.87M | 85.27M |
Total Debt | 473.56M | 415.67M | 419.88M | 314.67M | 228.32M | 20.38M | n/a | 76.54M | 78.96M | 29.67M | 29.44M | 29.4M | 4.2M | 12.86M |
Common Stock | 66K | 66K | 65K | 64K | 62K | 59K | 57K | 10K | 31K | 30K | 24K | 22.93K | 206.00 | 178.00 |
Retained Earnings | -1.05B | -951.8M | -729.19M | -634.6M | -659.21M | -624.83M | -600.08M | -477.61M | -404.58M | -321.13M | -248.72M | -169.19M | -106.05M | -72.73M |
Comprehensive Income | -1.95M | 1.37M | -1.82M | -616K | 220K | 122K | -13K | n/a | -1K | 20K | 8K | -7.58M | -4.95M | -3.15M |
Shareholders Equity | 263.1M | 313.63M | 439.95M | 433.11M | 366.31M | 194.98M | 131.28M | -29.15M | -5.93M | 63.47M | 54.57M | 115.54M | -106.05M | -71.29M |
Total Investments | 443.64M | 409.04M | 444.38M | 552.63M | 390.32M | 125.28M | 87.2M | 479K | 8.86M | 28.02M | 36.11M | 5.1M | n/a | n/a |